Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus
about
Acupuncture for adults with type 2 diabetes mellitusIntensive versus conventional glycaemic control for treating diabetic foot ulcersInterventions to improve safe and effective medicines use by consumers: an overview of systematic reviewsIntensive versus conventional glycaemic control for treating diabetic foot ulcersAcupuncture for adults with type 2 diabetes mellitusDifferent intensities of glycaemic control for pregnant women with pre-existing diabetesBromocriptine for type 2 diabetes mellitusPatient-adjusted versus health professional-adjusted insulin dosing for type 2 diabetes mellitusPolypharmacy in the Aging Patient: A Review of Glycemic Control in Older Adults With Type 2 DiabetesSafety and efficacy of gliclazide as treatment for type 2 diabetes: a systematic review and meta-analysis of randomized trialsGeldanamycin derivative ameliorates high fat diet-induced renal failure in diabetesGaps and barriers in the control of blood glucose in people with type 2 diabetes.Low socioeconomic status is associated with increased risk for hypoglycemia in diabetes patients: the Diabetes Study of Northern California (DISTANCE).Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trialsInsulin resistance, diabetes mellitus, and brain structure in bipolar disordersAtherosclerosis in systemic lupus erythematosus.Molecular Mechanisms of Retinoid Receptors in Diabetes-Induced Cardiac Remodeling.Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity.Effect of Intensive Versus Standard Blood Glucose Control in Patients With Type 2 Diabetes Mellitus in Different Regions of the World: Systematic Review and Meta-analysis of Randomized Controlled TrialsSitagliptin After Ischemic Stroke in Type 2 Diabetic Patients: A Nationwide Cohort Study.Cardiovascular disease and glycemic control in type 2 diabetes: now that the dust is settling from large clinical trials.Derivation and validation of a renal risk score for people with type 2 diabetesAmerican Geriatrics Society identifies five things that healthcare providers and patients should question.Risk factors of gender for renal progression in patients with early chronic kidney disease.Individualized glycaemic targets and pharmacotherapy in type 2 diabetes.Comparative effectiveness and cost-effectiveness of treat-to-target versus benefit-based tailored treatment of type 2 diabetes in low-income and middle-income countries: a modelling analysis.Effects of glycaemic management on diabetic kidney disease.Update in internal medicine: intensive glucose lowering does not reduce mortality in type 2 diabetes mellitus.Are we missing hypoglycaemia? Elderly patients with insulin-treated diabetes present to primary care frequently with non-specific symptoms associated with hypoglycaemia.
P2860
Q24186271-D05C87ED-F0A2-46DC-B72D-E697361C997AQ24186487-1DF043BB-FF11-45BB-825D-8FC6A0F87D44Q24197536-2FF667A3-34AB-49B3-B7A2-4FED3A1DB614Q24197832-E58E62A4-E106-4DCC-A31E-9556EEFF6F18Q24198114-8D396756-79B2-4528-85A8-65D89DA1EED5Q24201483-F01887EE-CA83-4932-87A9-B6468C3E301CQ24201924-1BBB9E3C-9371-4955-95E3-19027A91F776Q24202547-870935DE-2578-4074-861F-0C8C4AF7484BQ26767283-0B10B7BF-F74B-4481-B221-F3ECCB93D9E5Q27022613-72466DF8-FADC-4A52-9AE4-FAF6D50F3E56Q27307854-40B50DCF-1AC7-4A40-84A6-F64436B38DB9Q33641379-C5171858-9F16-44BF-80C5-DDDA3749FDCAQ33664937-1FB317F5-7571-459D-AD96-16C0BE67883BQ34083400-035EA360-42D3-48B5-B63E-06FB586583C1Q34357070-8FCBD3F1-EFC9-49B4-ADAF-2BB6DDCAB701Q35525108-4BE5CADB-45CB-4939-8DEB-8BB76C987D38Q35667311-6D3F27A1-F8FF-4A69-8EE3-85EE5A99585DQ36047225-BE05BFBE-453F-43E4-81DC-16A845B7E13DQ36141300-B6F2CD7D-3688-4EAE-B2CC-9605E4128261Q36196539-EC9D19BA-D26D-4559-A5FF-A884CD58F6C7Q37023878-852AF06D-0D4C-4D82-A030-859B52BD55BEQ37193467-4C8070BF-D762-4F08-B13E-24A29EBF076EQ37205382-65059754-D32B-4C55-87D5-A08706B806E0Q37605595-30377921-46A8-4DC3-9F0A-B8FFB81EBC63Q38109751-015AD9DE-05CD-49A2-AAD5-953C7D488331Q39310857-5B20634F-EC9C-45F6-A784-C696F9AAE7E7Q39345204-9941983A-CAA2-4BB4-B381-B269EC1727B6Q41616347-A013AB5E-9B9D-4330-A1AD-DA58CE77B8E0Q47568907-B231EA8A-37CB-41C2-B1DF-C85FB79D205B
P2860
Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Targeting intensive glycaemic ...... l for type 2 diabetes mellitus
@ast
Targeting intensive glycaemic ...... l for type 2 diabetes mellitus
@en
Targeting intensive glycaemic ...... l for type 2 diabetes mellitus
@en-gb
Targeting intensive glycaemic ...... l for type 2 diabetes mellitus
@nl
type
label
Targeting intensive glycaemic ...... l for type 2 diabetes mellitus
@ast
Targeting intensive glycaemic ...... l for type 2 diabetes mellitus
@en
Targeting intensive glycaemic ...... l for type 2 diabetes mellitus
@en-gb
Targeting intensive glycaemic ...... l for type 2 diabetes mellitus
@nl
prefLabel
Targeting intensive glycaemic ...... l for type 2 diabetes mellitus
@ast
Targeting intensive glycaemic ...... l for type 2 diabetes mellitus
@en
Targeting intensive glycaemic ...... l for type 2 diabetes mellitus
@en-gb
Targeting intensive glycaemic ...... l for type 2 diabetes mellitus
@nl
P2093
P2860
P3181
P1476
Targeting intensive glycaemic ...... l for type 2 diabetes mellitus
@en
P2093
Allan Vaag
Bianca Hemmingsen
Christina Hemmingsen
Søren S Lund
Thomas Almdal
P2860
P3181
P356
10.1002/14651858.CD008143.PUB2
P577
2011-06-15T00:00:00Z